IL1B and type 2 diabetes mellitus: Testosterone replacement therapy to testosterone-deficient men undergoing type 2 diabetes decreases the synthesis of the proinflammatory cytokines IL-1β, IL-6 and TNF-α in antigen-presenting cells [77].